NDC Compounded Drug 72627-2315-1 Sermorelin Acetate
Injection Intramuscular; Subcutaneous
Compounded Drug Product Information
NDC Crossover Products Matching Sermorelin Acetate
NDC crossover of Sermorelin Acetate with NDC 72627-2315 a human compounded drug with other similar products matching the same substance name (Sermorelin Acetate) and the same administration route (intramuscular; subcutaneous) or dosage form (injection).
NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
---|---|---|---|---|---|---|
26436-5031-9 | Sermorelin | Sermorelin 1mg/ml | 9 mL in 1 VIAL, MULTI-DOSE | Injection | Intramuscular | Hybrid Pharma |
26436-5607-9 | Sermorelin Acetate | Sermorelin Acetate 1mg/ml | 9 mL in 1 VIAL, MULTI-DOSE | Injection | Intramuscular | Hybrid Pharma |
26436-5607-9 | Sermorelin Acetate | Sermorelin Acetate 1mg/ml | 9 mL in 1 VIAL, MULTI-DOSE | Injection | Intramuscular | Hybrid Pharma |
72627-2313-1 | Sermorelin Acetate | Sermorelin Acetate | 3 mL in 1 VIAL, MULTI-DOSE | Injection | Intramuscular; Subcutaneous | Empower Pharmacy |
72627-2314-1 | Sermorelin Acetate | Sermorelin Acetate | 4.5 mL in 1 VIAL, MULTI-DOSE | Injection | Intramuscular; Subcutaneous | Empower Pharmacy |
Frequently Asked Questions
What is the NDC number assigned to Sermorelin Acetate?
Sermorelin Acetate was assigned by its manufacturer with NDC product code 72627-2315. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Sermorelin Acetate?
The NDC package code 72627-2315-1 was assigned to a 3 mL in 1 VIAL, MULTI-DOSE of sermorelin acetate administered intramuscular; subcutaneous via injection.
Who manufactures this product?
Sermorelin Acetate is manufactured by an outsourced facility and labeled by Empower Pharmacy. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 5 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Hybrid Pharma and Empower Pharmacy with NDC product codes 26436-5031-9, 26436-5607-9, 26436-5607-9, 72627-2313-1 and 72627-2314-1.